6,385 Shares in JPMorgan Chase & Co. (NYSE:JPM) Bought by HMV Wealth Advisors LLC
HMV Wealth Advisors LLC purchased a new position in JPMorgan Chase & Co. (NYSE:JPM) in the 4th quarter, according to the ...
Ripple says SEC lawsuit ‘over,’ Trump at DAS, and more: Hodler’s Digest, March 16 – 22
Ripple CEO Brad Garlinghouse says the SEC lawsuit is "over," Donald Trump speaks at Blockworks’ Digital Asset Summit: ...
Will new US SEC rules bring crypto companies onshore?
Why did US crypto firms move offshore, and what chances do they have of returning now that Trump is in office?
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 20, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.24, ...
Caleres, Inc. (NYSE:CAL) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 20, 2025 Caleres, Inc. beats earnings expectations. Reported EPS is $0.33, ...
Connor Clark & Lunn Investment Management Ltd. Grows Position in Red River Bancshares, Inc. (NASDAQ:RRBI)
Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of Red River Bancshares, Inc. (NASDAQ:RRBI – ...
Atea Pharmaceuticals Issues Statement Regarding Director Nominations
No Shareholder Action is Required at this TimeBOSTON, March 21, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or ...
Toncoin traders take profits as crypto VCs invest $400M in TON
The $400 million VC investment sparked an immediate profit-taking frenzy among Toncoin traders. As a result, TON price ...
Should You Worry When Insiders Sell Their Shares? Here's How To Find Out
Learn to interpret insider stock sales like Tesla's recent $118M selloff. Discover the key differences between planned 10b5-1 ...
SEC to Lose About 500 Staffers to Buyout, Resignation Offers
About 500 staffers at the Securities & Exchange Commission have agreed to leave the agency in response to its $50,000 buyout ...
Opus Genetics Announces Pricing of Public Offering and Concurrent Private Placement with Proceeds of Over $20 Million
The public offering was led by Perceptive Advisors and Nantahala Capital, with participation from other new institutional biotech investors. Company CEO George Magrath and board chairman Cam Gallagher ...